Acupuncture course potential treatment for fatigue

Research abstract:

Background:

The causes of chronic fatigue syndrome (CFS) and idiopathic chronic fatigue (ICF) are not clearly known, and there are no definitive treatments for them. Therefore, patients with CFS and ICF are interested in Oriental medicine or complementary and alternative medicine.

For this reason, the effectiveness of complementary and alternative treatments should be verified. We investigated the effectiveness of two forms of acupuncture added to usual care for CFS and ICF compared to usual care alone.

Methods:

A three-arm parallel, non-blinded, randomized controlled trial was performed in four hospitals. We divided 150 participants into treatment and control groups at the same ratio. The treatment groups (Group A, body acupuncture; Group B, Sa-am acupuncture) received 10 sessions for 4 weeks. The control group (Group C) continued usual care alone. The primary outcome was the Fatigue Severity Scale (FSS) at 5 weeks after randomization. Secondary outcomes were the FSS at 13 weeks and a short form of the Stress Response Inventory (SRI), the Beck Depression Inventory (BDI), the Numeric Rating Scale (NRS), and the EuroQol-5 Dimension (EQ-5D) at 5 and 13 weeks.

 Results:

Group A showed significantly lower FSS scores than Group C at 5 weeks (P = 0.023). SRI scores were significantly lower in the treatment groups than in the control group at 5 (Group A, P = 0.032; B, P <0.001) and 13 weeks (Group A, P = 0.037; B, P <0.001). Group B showed significantly lower BDI scores than Group C at 13 weeks (P = 0.007). NRS scores from the treatment groups were significantly reduced compared to control at 5 (Group A and B, P <0.001) and 13 weeks (Group A, P = 0.011; B, P = 0.002).

Conclusions:

Body acupuncture for 4 weeks in addition to usual care may help improve fatigue in CFS and ICF patients.

Acupuncture for chronic fatigue syndrome and idiopathic chronic fatigue: a multicenter, non-blinded, randomized controlled trial. Kim JE, et al in Trials, 2015 Jul 26; 16: 314

Posted in News | Tagged , | Comments Off on Acupuncture course potential treatment for fatigue

Is there enough sun in Britain for healthy vitamin D levels?

The Guardian reports:

Intake should be boosted with supplements, say official health advisors in draft recommendations that could lead to new guidance

Public Health England says more than one in five people have low levels of vitamin D, which is essential for healthy teeth and bones.

People in Britain should boost their vitamin D intake with supplements because of a lack of bright sunshine to provide it naturally, government health advisers have suggested. The British weather prevents much of the population from receiving healthy amounts of the essential vitamin from sunlight, and natural food sources alone are not enough to boost levels, according to the scientific advisory committee on nutrition (SACN).

The SACN, an independent advisory body to the government, made the recommendation after studying the links between vitamin D levels and a range of health problems, including musculoskeletal health, heart disease, type 1 diabetes, cancer and multiple sclerosis.

How to avoid Vitamin D deficiency
Current government advice is that at-risk groups, including pregnant women, children up to the age of five, adults over 65 and people with darker skin as well as those who do not expose their skin to sunlight should take a daily vitamin D supplement. But if SACN’s draft recommendations are adopted, it could lead to new guidance affecting the whole population.

Dr Adrian Martineau, an expert on vitamin D at Barts and the London School of Medicine and Dentistry, said the new advice marked a “sea change” in thinking. He told the Independent on Sunday: “Before this, the general assumption was that adults were able to make all the vitamin D they needed from sunshine, and didn’t need to have any dietary or supplementary intake. The action of sunlight on the skin in the UK is highly variable for different populations depending on the time of year and the latitude – you’ll get more UVB in Brighton than in John O’Groats – and finally, how much skin is exposed and the colour of skin.

“SACN was right to say that we can’t rely on sunshine in the UK to meet the vitamin D requirements. That’s a major and important change. It’s a big step forward that this is now officially recognised.”

More than one in five people have low levels of vitamin D, which is essential for keeping teeth and bones healthy, according to recent data published by Public Health England.

Sunshine and vitamin D: why cloudy skies are bad for our health

A lack of the essential nutrient can cause rickets in children, and in adults can lead to osteomalacia, causing the person’s bones to become weak and painful, and hampering mobility. The best source of vitamin D is sunlight, and it only occurs naturally in a few foods, such as oily fish and eggs.

The draft vitamin D and health report said: “It is proposed that the recommended nutrient intake is applicable throughout the year, as a precautionary measure, to cover population groups in the UK identified to be at risk of minimal sunshine exposure as well as unidentified individuals in the population with minimal sunshine exposure who would be at risk in summer.

“Since it is difficult to achieve [the recommended intake] from natural food sources alone, it is recommended that consideration is given to strategies for the UK population to achieve the recommended nutrient intake.”

Professor Hilary Powers, chair of the SACN vitamin D working group, cautioned that recommendations had yet to be finalised. She said: “It is important to remember that this vitamin D report is a draft, so the recommendations may change after the consultation period. SACN will be publishing their final recommendations in early 2016 and until then the government’s current advice on vitamin D remains in place.”

Guardian article: Britain not sunny enough for healthy vitamin D levels, say experts

Posted in News | Tagged , , , | Comments Off on Is there enough sun in Britain for healthy vitamin D levels?

POTS

Research abstract:

Postural tachycardia syndrome (POTS) is a form of chronic orthostatic intolerance for which the hallmark physiological trait is an excessive increase in heart rate with assumption of upright posture.

The orthostatic tachycardia occurs in the absence of orthostatic hypotension and is associated with a >6-month history of symptoms that are relieved by recumbence. The heart rate abnormality and orthostatic symptoms should not be caused by medications that impair autonomic regulation or by debilitating disorders that can cause tachycardia.

POTS is a “final common pathway” for a number of overlapping pathophysiologies, including an autonomic neuropathy in the lower body, hypovolemia, elevated sympathetic tone, mast cell activation, deconditioning, and autoantibodies.

Not only may patients be affected by more than one of these pathophysiologies but also the phenotype of POTS has similarities to a number of other disorders, e.g., chronic fatigue syndrome, Ehlers-Danlos syndrome, vasovagal syncope, and inappropriate sinus tachycardia. POTS can be treated with a combination of non-pharmacological approaches, a structured exercise training program, and often some pharmacological support.

Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance, by EM Garland, JE Cerledonio, SR Raj in Curr Neurol Neurosci Rep. 2015 Sep;15(9):583

Posted in News | Tagged , | Comments Off on POTS

Luteolin – potential treatment for brain fog, inflammation & obesity?

Review article:

Brain “fog” is a constellation of symptoms that include reduced cognition, inability to concentrate and multitask, as well as loss of short and long term memory. Brain “fog” characterizes patients with autism spectrum disorders (ASDs), celiac disease, chronic fatigue syndrome, fibromyalgia, mastocytosis, and postural tachycardia syndrome (POTS), as well as “minimal cognitive impairment,” an early clinical presentation of Alzheimer’s disease (AD), and other neuropsychiatric disorders.

Brain “fog” may be due to inflammatory molecules, including adipocytokines and histamine released from mast cells (MCs) further stimulating microglia activation, and causing focal brain inflammation.

Recent reviews have described the potential use of natural flavonoids for the treatment of neuropsychiatric and neurodegenerative diseases. The flavone luteolin has numerous useful actions that include: anti-oxidant, anti-inflammatory, microglia inhibition, neuroprotection, and memory increase.

A liposomal luteolin formulation in olive fruit extract improved attention in children with ASDs and brain “fog” in mastocytosis patients. Methylated luteolin analogs with increased activity and better bioavailability could be developed into effective treatments for neuropsychiatric disorders and brain “fog.”

Brain “fog”, inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin by Theoharis C Theoharides, Julia M. Stewart, Erifili Hatziagelaki and Gerasimos Kolaitis in Front. Neurosci., 03 July 2015

 

 

Posted in News | Tagged , , , , | Comments Off on Luteolin – potential treatment for brain fog, inflammation & obesity?

Lyme tests brought into question?

Cort Johnson comments on recent research:

There has been a growing consensus  that whatever chronic Lyme disease is it’s not due to the bacteria. This concensus has been based on studies indicating that short term antibiotic treatment following an infection, causes a dramatic reduction in antibodies. That drop in antibody levels is believed to reflect the immune system turning itself off, because of the bacteria, Borrelia burgdorferi, is gone.

This study overturned that idea completely.

Suppression of Long-Lived Humoral Immunity Following Borrelia burgdorferi Infection. Rebecca A. Elsner, Christine J. Hastey, Kimberly J. Olsen, Nicole Baumgarth PLOS Pathogens | DOI:10.1371/journal.ppat.1004976 July 2, 2015

Borrelia has developed several tricks to evade the immune system. It can inhibit complement activity and disguise itself by varying the proteins found on its surface. How quickly the infection spreads may be a key factor in how easy it is to suppress. Infections that stay localized are more easily dealt with. Wider spreading infections are more difficult to contain. Studies suggest that adaptive or long term immunity is hard to come by.

Borrelia appears to head straight for the heart of the immune system  – the lymph nodes – where, at least in mice, it inhibits the adaptive immune response by attacking the centers of T and B cell production.  That, along with the antigen switching, helps explain the difficulty the immune response has in containing the infection.

The Study

First they gave the mice Borrelia. They observed the infection take hold and spread and then they treated the mice with antibiotics. They observed a strong antibody response. That, and antibiotics quickly brought the antibody levels down – suggesting that the infection had been resolved. (Tissue analyses done later indicated that antibiotic treatment had, in fact,  vanquished Borrelia. In the non-antibiotic treated mice it was still present.)

Then they dug deeper into the post-bacterial infection stage. At the end of the antibiotic regimen they exposed the mice to Borrelia antigens again. The immune system, at that point, should be able to quickly jump on any hint of Borrelia and mount a huge immune response, but it refused to budge. When they challenged the mice with an actual Borrelia infection, all the mice – whether they’d been treated with antibiotics or not – came down with Borrelia.  When they hit the mice an influenza vaccine, guaranteed to crank up the immune system, the antibody response to the influenza was weakened as well.

Somehow, during the initial infection, Borrelia had taken a hammer to the adaptive or long term immune response. Looking deeper they found structural alterations in the  germinal centers that produce the long term immune response. Further study indicated that antibody response was significantly blunted, not just to Borrelia antigens – but to others as well.

They continued following the mice.  They found significant immune suppression, lasting from a period about one month into the infection to about six months after it. During that period, immune system was essentially wide open to the Borellia bacteria and perhaps to other past infections. It did not respond to vaccines either.
The study found that antibiotics do appear to wipe out Borrelia and the immune system, in mice, at least, does appear to dust itself off after “many months” and get back to work. In the interim, though, people with Borrelia infections may be more vulnerable to further Borrelia or perhaps other infections (including infections that ticks carry.) ( Could Borrelia interfere with antibody response to herpesviruses? Could the immune suppression it invokes lead to herpesvirus reactivation?)

The Post Infection Period
Researchers are more and more recognizing that the effects of infection do not stop with an apparent vanquishing of the virus. A recent study found that measles infections suppress immune functioning for up to three years. The suppression occurs in a different way than Borrelia. Apparently the immune system gets so excited upon being confronted with measles that it throws all it’s memory cells at the virus –  ignoring any other pathogens.  The increased death rates seen in the three years following measles infections are not due to measles, but to other infections taking advantage of a weakened immune system.

The reports of post-Ebola fatigue and pain syndromes occurring in some Ebola survivors, are another compelling example of post-infectious problems. We know that cytomegalovirus infections reset the workings of much of the immune system for decades, even in healthy people. The point is that more understanding is slowly emerging of radical changes that can present themselves in the post-infection period.  That’s good news for the infectious subset in ME/CFS and fibromyalgia.

Testing Issues

This study introduced more uncertainty regarding Lyme diagnoses – an area that already comes with considerable uncertainty. It found that low levels of antibody titers to Borrelia in the six months or so following an infection are more indicative of a vanquished immune system than a vanquished bacteria. This suggests that antibody tests taken at a doctors office from a month to six months after a tick bite may be largely useless.  Tests taken before or after this period, if I’m reading this study correctly, would likely be accurate.

It should be noted that this was a mouse study. While the mice did recapitulate the same up and down antibody responses known to occur in humans, the study findings have not been replicated in humans.

Lyme Induced Immune Suppression May Bring Lyme Tests into Question, by Cort Johnson in Health Rising, July 13, 2015

 

Posted in News | Tagged , , | Comments Off on Lyme tests brought into question?

Increased risk of organic erectile dysfunction in CFS

Research abstract:

Chronic fatigue syndrome (CFS) is a complex disorder characterized by profound and persistent fatigue and several comorbidities.

CFS was previously reported to be associated with female sexual dysfunction. We propose that CFS might also be associated with organic erectile dysfunction (organic ED). We conducted a retrospective cohort study by using data from the National Health Insurance (NHI) Research Database. We identified 2156 male patients who were newly diagnosed with CFS between January 1, 2003 and December 31, 2006.

After excluding those younger than 20 years and prevalent cases, 1976 patients were subjected to analysis, and 7904 people served as healthy controls. All study subjects were followed up from the index date to the date of organic ED diagnosis, withdrawal from the NHI program, or the end of 2011.

Compared with the non-CFS cohort, the incidence density rate of organic ED was 1.88-fold higher than that in the CFS cohort (3.23 vs. 1.73 per 1000 person-years) with an adjusted hazard ratio (HR) of 1.88 (95% CI = 1.26-2.81) when adjusting for sex and comorbidities. The combined impacts of patients with CFS and cardiovascular disease (CVD), diabetes mellitus (DM), chronic kidney disease (CKD), depression, and anxiety showed a significant by joint association with organic ED risk compared with patients with no CFS and no counterpart comorbidity.

The greatest magnitude of adjusted HR of ED for CFS was observed in individuals without any comorbidity (3.87, 1.95-7.66). The incidence of organic ED is higher among males aged 40 years and over for both CFS and non-CFS cohorts. As the number of comorbidity increases, the incidence of organic ED increases in males without CFS. Higher incidence of organic ED was observed in males with CVD, DM, CKD, depression, or anxiety for both CFS and non-CFS cohorts.

Increased risk of organic erectile dysfunction in patients with chronic fatigue syndrome: a nationwide population-based cohort study, by Chao CH, et al. in Andrology, 2015 Jul; 3(4): 666-71

 

Posted in News | Tagged | Comments Off on Increased risk of organic erectile dysfunction in CFS

First Class student overcomes CFS to graduate in Bangor

Article from Bangor University website:

A Psychology student who credits Bangor University for ‘taking a chance’ on her has graduated with a First Class Honours degree.

Ashleigh Johnstone

Ashleigh Johnstone from Douglas on the Isle of Man has battled Chronic Fatigue Syndrome since high school and her health issues meant that she struggled with her GCSE and A Level exams. But despite setbacks, Ashleigh aspired to study at university.

Ashleigh said, “I have always loved education and looked to the next step  – in high school I was very excited to move to university.

“However, my plans hit a bit of a snag when I was diagnosed with Chronic Fatigue Syndrome. This severely impacted on my education, as there were many days where I could barely get out of bed. Luckily, my school – St Ninian’s High School – was supportive and they helped facilitate a plan for me to be able to complete my English and Maths GCSEs through online learning.

“At A Level they again allowed me to do what I was able to at the time. My health had started to improve and I was able to start considering university, which is something I was worried I would have to miss out on.

“My mum took me along to the Higher Education Fair on the Isle of Man and I spoke to a representative from Bangor University who explained that they would still consider my application, despite only having two A Levels  – and now here I am graduating!”

Once Ashleigh began studying her degree in Psychology with Neuropsychology, she wasted no time in getting involved in activities within the School of Psychology, serving as a Course Representative, Mentor, Open Day Guide and Email buddy. She also travelled to Krakow and Auschwitz in Poland on a field trip in her second year.

Ashleigh explained, “I have genuinely loved my three years at Bangor and have tried to make the most of my time here. At some points throughout my degree I struggled with my health – with Chronic Fatigue Syndrome you can have periods where you feel great, and then you can start to relapse again.

“After a few months at university I really started to struggle and considered dropping out because of my health. However, the Disability Services and my tutors were wonderful and have always been very understanding.

“It’s very exciting to be graduating. There were a few occasions where I didn’t think I would make it to graduation, however the staff in the School of Psychology were all so supportive that I kept pushing through.

“It is also slightly bittersweet; I’m going to miss all of my friends who are leaving Bangor, but I’ve got a Masters and PhD waiting for me in September so I’m looking forward to starting that.”

During the summer between second and third year Ashleigh took part in a summer research internship in the psychology department, which she believes helped pave the way for her to pursue a postgraduate degree.

“I learnt so much about psychological research during those two months, and I believe the experience really helped with my postgraduate applications,” said Ashleigh.

“I have been offered a fully funded Masters and PhD at Bangor that I’ll be starting in September. It’s a really exciting project, and it means I get to stay at the university!

“I’m so grateful for all the opportunities Bangor has given me, and I’m looking forward to the next four years!”

First Class student overcomes health problems to graduate, Bangor University website, 13 July 2015 [includes video of Ashleigh]

Posted in News | Tagged , , | Comments Off on First Class student overcomes CFS to graduate in Bangor

CoQ10 with NADH – potential treatment for fatigue in CFS

Research abstract:

Background & aims: Chronic Fatigue Syndrome (CFS) is a complex condition, characterized by severe disabling fatigue with no known cause, no established diagnostic tests, and no universally effective treatment. Several studies have proposed symptomatic treatment with coenzyme Q10 (CoQ10) and nicotinamide adenine dinucleotide (NADH) supplementation. The primary endpoint was to assess the effect of CoQ10 plus NADH supplementation on age-predicted maximum heart rate (max HR) during a cycle ergometer test. Secondary measures included fatigue, pain and sleep.

Methods: A proof-of-concept, 8-week, randomized, controlled, double-blind trial was conducted in 80 CFS patients assigned to receive either CoQ10 plus NADH supplementation or matching placebo twice daily. Maximum HR was evaluated at baseline and at end of the run-in period using an exercise test. Fatigue, pain and sleep were evaluated at baseline, and then reassessed at 4- and 8-weeks through self-reported questionnaires.

Results: The CoQ10 plus NADH group showed a significant reduction in max HR during a cycle ergometer test at week 8 versus baseline (P = 0.022). Perception of fatigue also showed a decrease through all follow-up visits in active group versus placebo (P = 0.03). However, pain and sleep did not improve in the active group. Coenzyme Q10 plus NADH was generally safe and well tolerated.

Conclusions: Our results suggest that CoQ10 plus NADH supplementation for 8 weeks is safe and potentially effective in reducing max HR during a cycle ergometer test and also on fatigue in CFS. Further additional larger controlled trials are needed to confirm these findings.

Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome – A randomized, controlled, double-blind trial, by J Castro-Marrero J et al. in Clinical Nutrition, 2015 July 10

 

Posted in News | Tagged , , , , , | Comments Off on CoQ10 with NADH – potential treatment for fatigue in CFS

Gender differences in CFS

Research abstract:

Background and objectives:

Chronic fatigue syndrome (CFS) is a chronic condition that predominantly affects women. To date, there are few epidemiologic studies on CFS in men. The objective of the study was to assess whether there are gender-related differences in CFS, and to define a clinical phenotype in men.

Patients and methods

A prospective, cross-sectional cohort study was conducted including CFS patients at the time of diagnosis. Sociodemographic data, clinical variables, comorbid phenomena, fatigue, pain, anxiety/depression, and health quality of life, were assessed in the CFS population. A comparative study was also conducted between genders.

Results

The study included 1309 CFS patients, of which 119 (9.1%) were men. The mean age and symptoms onset were lower in men than women. The subjects included 30% single men vs. 15% single women, and 32% of men had specialist work vs. 20% of women. The most common triggering factor was an infection. Widespread pain, muscle spasms, dizziness, sexual dysfunction, Raynaud’s phenomenon, morning stiffness, migratory arthralgias, drug and metals allergy, and facial oedema were less frequent in men. Fibromyalgia was present in 29% of men vs. 58% in women. The scores on physical function, physical role, and overall physical health of the SF-36 were higher in men. The sensory and affective dimensions of pain were lower in men.

Conclusions

The clinical phenotype of the men with CFS was young, single, skilled worker, and infection as the main triggering agent. Men had less pain and less muscle and immune symptoms, fewer comorbid phenomena, and a better quality of life.
Gender differences in chronic fatigue syndrome, by M Faro et al. in Reumatol Clin, 2015 Jul 16

Posted in News | Tagged , | Comments Off on Gender differences in CFS

Increased risk of CFS following atopy

Research abstract:

Several hypotheses have been proposed to explain the etiopathogenesis of chronic fatigue syndrome (CFS), including immune dysregulation. However, few population-based prospective cohort studies have been conducted on CFS and atopy. We investigated the relationship between atopy and CFS by using a population-based cohort study.

In this prospective, population-based cohort study of the National Health Insurance Research Database, we identified 42,558 patients with atopy and 170,232 patients without atopy from 2005 to 2007 with follow-up to 2011. The incidence rates and risks for CFS were estimated using Cox proportion hazards regression.

The overall incidence rate of CFS was higher in the atopy cohort compared with the nonatopy cohort (1.37 versus 0.87 per 1000 person-year), with an adjusted hazard ratio of 1.48 (95% confidence interval 1.30-1.69). The risk of CFS in the atopy cohort increased 1.47- to 1.50-fold for each nonexisting comorbidity. Patients with numerous atopic symptoms exhibited a biological gradient of increasing risk for CFS, and the risk changed significantly after adjustment for age, sex, and comorbidities, increasing from 1.46- to 2.59-fold.

We revealed that atopy is associated with CFS, particularly in patients with numerous atopic syndromes. The actual mechanism for CFS development in patients with atopy remains unclear and requires further investigation. We recommend researching the subsequent fatigue symptom in patients with atopy, particularly those with multiple atopic syndromes.

Increased risk of Chronic Fatigue Syndrome following atopy: a population-based study, by Yang TY, Kuo HT, Chen HJ, Chen CS, Lin WM, Tsai SY, Kuo CN, Kao CH in Medicine (Baltimore) 2015 Jul;94(29):e1211.

Posted in News | Tagged , | Comments Off on Increased risk of CFS following atopy